Remdesivir, convalescent plasma use based on limited available evidence: Health ministry

The ministry clarified that remdesivir has been included as an "investigational therapy" only for the purpose of restricted emergency use following certain news reports regarding the use of the drug as part of the clinical management protocols for COVID-19 and its availability in the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30Kf8bN
via IFTTT